Jacobi Capital Management LLC Eli Lilly & CO Transaction History

Jacobi Capital Management LLC

$1.29 Billion
Q3 2024

A detailed history of Jacobi Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jacobi Capital Management LLC holds 12,628 shares of LLY stock, worth $10 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

12,628

Previous 12,677 0.39%

Holding current value

$10 Million

Previous $11.5 Million 2.53%

% of portfolio

0.87%

Previous 1.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $37,834 - $47,040	-49 Reduced 0.39%	12,628 $11.2 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $39,867 - $49,997	-55 Reduced 0.43%	12,677 $11.5 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $1.26 Million - $1.69 Million	-2,134 Reduced 14.35%	12,732 $9.9 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $802,490 - $946,030	-1,528 Reduced 9.32%	14,866 $8.67 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $507,729 - $699,982	1,168 Added 7.67%	16,394 $8.81 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $170,108 - $227,455	-485 Reduced 3.09%	15,226 $7.14 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $178,612 - $209,771	575 Added 3.8%	15,711 $5.4 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $65,596 - $76,432	-204 Reduced 1.33%	15,136 $5.54 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $182,335 - $207,790	-615 Reduced 3.85%	15,340 $4.96 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $27,315 - $32,072	-98 Reduced 0.61%	15,955 $5.17 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $9,387 - $11,666	-40 Reduced 0.25%	16,053 $4.6 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $43,845 - $54,412	195 Added 1.23%	16,093 $4.45 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $140,272 - $172,625	-633 Reduced 3.83%	15,898 $3.67 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $33,943 - $43,905	188 Added 1.15%	16,531 $3.8 Million
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $80,352 - $104,020	489 Added 3.08%	16,343 $3.05 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $21,525 - $28,483	165 Added 1.05%	15,854 $3.13 Million
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $19,008 - $21,986	130 Added 0.84%	15,689 $2.26 Million
Q2 2020 Aug 04, 2020	BUY	$136.42 - $164.18 $1.81 Million - $2.17 Million	13,239 Added 570.65%	15,559 $2.56 Million
Q2 2020 Jul 27, 2020	SELL	$136.42 - $164.18 $1.84 Million - $2.22 Million	-13,500 Reduced 85.34%	2,320 $2.56 Million
Q1 2020 Apr 24, 2020	SELL	$119.05 - $147.35 $318,815 - $394,603	-2,678 Reduced 14.48%	15,820 $2.38 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $9,622 - $11,918	90 Added 0.49%	18,498 $2.52 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $99,528 - $108,261	-932 Reduced 4.82%	18,408 $2.01 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $1.74 Million - $2.03 Million	15,716 Added 433.66%	19,340 $2.15 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $8,904 - $10,481	80 Added 2.26%	3,624 $470,000
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $177,700 - $199,077	1,678 Added 89.92%	3,544 $410,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $9,015 - $11,267	105 Added 5.96%	1,866 $200,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $6,964 - $7,992	92 Added 5.51%	1,761 $150,000
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $4,007 - $4,730	-54 Reduced 3.13%	1,669 $126,000
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $409 - $439	5 Added 0.29%	1,723 $148,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $52,484 - $58,252	681 Added 65.67%	1,718 $150,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,037	1,037 $85,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Eli Lilly & CO Transaction History